These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22824178)

  • 21. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Public health economic aspects of antiretroviral therapy. Can we afford to do less?].
    Stoll M; Claes C; Schulte E; Körner T; von der Schulenburg JM; Schmidt R
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():45-9. PubMed ID: 10863311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa.
    Wilkinson D; Floyd K; Gilks CF
    S Afr Med J; 2000 Aug; 90(8):794-8. PubMed ID: 11022629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. National poverty reduction strategies and HIV/AIDS governance in Malawi: a preliminary study of shared health governance.
    Wachira C; Ruger JP
    Soc Sci Med; 2011 Jun; 72(12):1956-64. PubMed ID: 20675024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Option B+ for the prevention of mother-to-child transmission of HIV infection in developing countries: a review of published cost-effectiveness analyses.
    Karnon J; Orji N
    Health Policy Plan; 2016 Oct; 31(8):1133-41. PubMed ID: 27016949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How HIV treatment advances affect the cost-effectiveness of prevention.
    Pinkerton SD; Holtgrave DR
    Med Decis Making; 2000; 20(1):89-94. PubMed ID: 10638541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and economic impact of new antiretroviral treatments].
    Moreno Guillén S; Pérez Elías MJ
    Rev Clin Esp; 1999 Feb; 199(2):53-4. PubMed ID: 10216393
    [No Abstract]   [Full Text] [Related]  

  • 28. Costs associated with combination antiretroviral therapy in HIV-infected patients.
    Yazdanpanah Y
    J Antimicrob Chemother; 2004 Apr; 53(4):558-61. PubMed ID: 14985277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cost effectiveness of antiretroviral therapy for HIV disease.
    Laurence J
    N Engl J Med; 2001 Jul; 345(1):68; author reply 68-9. PubMed ID: 11439961
    [No Abstract]   [Full Text] [Related]  

  • 30. Cost-effectiveness of optimized background therapy plus maraviroc for previously treated patients with R5 HIV-1 infection from the perspective of the Spanish health care system.
    Moreno S; González J; Lekander I; Martí B; Oyagüez I; Sánchez-de la Rosa R; Casado MA
    Clin Ther; 2010 Dec; 32(13):2232-45. PubMed ID: 21316539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling the long-term outcomes and costs of HIV antiretroviral therapy using HIV RNA levels: application to a clinical trial.
    Cook J; Dasbach E; Coplan P; Markson L; Yin D; Meibohm A; Nguyen BY; Chodakewitz J; Mellors J
    AIDS Res Hum Retroviruses; 1999 Apr; 15(6):499-508. PubMed ID: 10221527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cost effectiveness of antiretroviral therapy for HIV disease.
    Messori A; Trippoli S; Vaiani M
    N Engl J Med; 2001 Jul; 345(1):68; author reply 68-9. PubMed ID: 11439960
    [No Abstract]   [Full Text] [Related]  

  • 33. The impact of visa status and Medicare eligibility on people diagnosed with HIV in Western Australia: a qualitative report.
    Herrmann S; Wardrop J; John M; Gaudieri S; Lucas M; Mallal S; Nolan D
    Sex Health; 2012 Nov; 9(5):407-13. PubMed ID: 22950904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effectiveness and cost implications of task-shifting in the delivery of antiretroviral therapy to HIV-infected patients: a systematic review.
    Mdege ND; Chindove S; Ali S
    Health Policy Plan; 2013 May; 28(3):223-36. PubMed ID: 22738755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Providing antiretroviral therapy for HIV infection.
    Steinbrook R
    N Engl J Med; 2001 Mar; 344(11):844-6. PubMed ID: 11248164
    [No Abstract]   [Full Text] [Related]  

  • 36. Cost and threshold analysis of positive charge, a multi-site linkage to HIV care program in the United States.
    Kim JJ; Maulsby C; Zulliger R; Jain K; ; Charles V; Riordan M; Davey-Rothwell M; Holtgrave DR
    AIDS Behav; 2015 Oct; 19(10):1735-41. PubMed ID: 26139421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).
    ; Berenguer J; Polo R; Aldeguer JL; Lozano F; Aguirrebengoa K; Arribas JR; Blanco JR; Boix V; Casado JL; Clotet B; Crespo M; Domingo P; Estrada V; García F; Gatell JM; González-García J; Gutiérrez F; Iribarren JA; Knobel H; Llibre JM; Locutura J; López JC; Miró JM; Moreno S; Podzamczer D; Portilla J; Pulido F; Ribera E; Riera M; Rubio R; Santos J; Sanz-Moreno J; Sanz J; Téllez MJ; Tuset M; Rivero A
    Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):544-56. PubMed ID: 26021186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Cost and Threshold Analysis of Retention in Care (RiC): A Multi-Site National HIV Care Program.
    Maulsby C; Jain KM; Weir BW; Enobun B; Riordan M; Charles VE; ; Holtgrave DR
    AIDS Behav; 2017 Mar; 21(3):643-649. PubMed ID: 27873083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Assessment of the impact of the new health legislation on illegal immigrants in Spain: the case of human immunodeficiency virus infection].
    Pérez-Molina JA; Pulido Ortega F;
    Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):472-8. PubMed ID: 22939565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.